Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Folding | 29 | 2024 | 123 | 6.500 |
Why?
|
| Quantum Dots | 6 | 2025 | 38 | 4.790 |
Why?
|
| Disulfides | 20 | 2022 | 92 | 3.880 |
Why?
|
| Carbon | 7 | 2025 | 127 | 3.690 |
Why?
|
| Ribonuclease, Pancreatic | 20 | 2022 | 30 | 3.380 |
Why?
|
| Neurodegenerative Diseases | 8 | 2024 | 138 | 3.300 |
Why?
|
| Proteins | 10 | 2022 | 383 | 2.970 |
Why?
|
| Nanoparticles | 7 | 2025 | 449 | 2.640 |
Why?
|
| Amyloid | 5 | 2025 | 66 | 2.480 |
Why?
|
| Muramidase | 4 | 2025 | 31 | 2.170 |
Why?
|
| Lactoglobulins | 3 | 2025 | 13 | 1.950 |
Why?
|
| Endoplasmic Reticulum | 5 | 2018 | 108 | 1.610 |
Why?
|
| alpha-Synuclein | 4 | 2022 | 59 | 1.520 |
Why?
|
| Reactive Oxygen Species | 10 | 2025 | 518 | 1.510 |
Why?
|
| Protein Disulfide-Isomerases | 4 | 2014 | 12 | 1.390 |
Why?
|
| Animals | 42 | 2025 | 16695 | 1.280 |
Why?
|
| Oxidative Stress | 5 | 2022 | 990 | 1.200 |
Why?
|
| Biocompatible Materials | 3 | 2025 | 106 | 1.110 |
Why?
|
| Ellagic Acid | 2 | 2020 | 4 | 1.110 |
Why?
|
| Oxidation-Reduction | 20 | 2022 | 448 | 1.070 |
Why?
|
| Amyloidosis | 3 | 2022 | 38 | 1.070 |
Why?
|
| Caenorhabditis elegans | 2 | 2025 | 78 | 1.040 |
Why?
|
| Apoptosis | 7 | 2024 | 1541 | 1.040 |
Why?
|
| Nanostructures | 4 | 2022 | 158 | 1.020 |
Why?
|
| Polyvinyl Chloride | 1 | 2025 | 4 | 0.950 |
Why?
|
| Nitrogen | 2 | 2025 | 83 | 0.940 |
Why?
|
| Carrier Proteins | 4 | 2016 | 318 | 0.940 |
Why?
|
| Humans | 38 | 2025 | 42163 | 0.930 |
Why?
|
| Nerve Tissue Proteins | 4 | 2016 | 382 | 0.910 |
Why?
|
| Rotenone | 4 | 2020 | 17 | 0.890 |
Why?
|
| Disease | 1 | 2024 | 21 | 0.890 |
Why?
|
| Caprylates | 1 | 2024 | 10 | 0.860 |
Why?
|
| Curcumin | 3 | 2010 | 115 | 0.840 |
Why?
|
| Caffeic Acids | 1 | 2023 | 5 | 0.830 |
Why?
|
| Fluorocarbons | 1 | 2024 | 28 | 0.830 |
Why?
|
| Neuroblastoma | 2 | 2022 | 134 | 0.820 |
Why?
|
| Gene Transfer Techniques | 1 | 2023 | 53 | 0.820 |
Why?
|
| Cattle | 17 | 2022 | 505 | 0.820 |
Why?
|
| Graphite | 1 | 2024 | 61 | 0.800 |
Why?
|
| Kinetics | 12 | 2022 | 698 | 0.800 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2022 | 37 | 0.730 |
Why?
|
| Herbicides | 1 | 2022 | 44 | 0.730 |
Why?
|
| Nanotechnology | 2 | 2020 | 176 | 0.690 |
Why?
|
| Protein Conformation | 10 | 2021 | 420 | 0.690 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 8 | 0.680 |
Why?
|
| Alanine | 1 | 2020 | 33 | 0.680 |
Why?
|
| Fullerenes | 1 | 2021 | 31 | 0.680 |
Why?
|
| Drug Discovery | 3 | 2018 | 106 | 0.670 |
Why?
|
| Cell Line, Tumor | 9 | 2025 | 2598 | 0.630 |
Why?
|
| Nanotubes, Carbon | 1 | 2021 | 87 | 0.630 |
Why?
|
| Protein Transport | 4 | 2017 | 295 | 0.630 |
Why?
|
| Microscopy, Atomic Force | 1 | 2019 | 62 | 0.620 |
Why?
|
| Selenium | 1 | 2021 | 150 | 0.610 |
Why?
|
| Parkinsonian Disorders | 2 | 2016 | 42 | 0.610 |
Why?
|
| Paraquat | 3 | 2023 | 21 | 0.590 |
Why?
|
| Antiviral Agents | 1 | 2020 | 189 | 0.590 |
Why?
|
| Neoplasms | 5 | 2024 | 1341 | 0.590 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2019 | 94 | 0.580 |
Why?
|
| Neuroprotective Agents | 3 | 2024 | 267 | 0.580 |
Why?
|
| Computational Biology | 1 | 2021 | 324 | 0.580 |
Why?
|
| Ribonucleases | 7 | 2008 | 32 | 0.580 |
Why?
|
| Halogens | 1 | 2017 | 1 | 0.550 |
Why?
|
| Antioxidants | 2 | 2024 | 439 | 0.540 |
Why?
|
| Enzyme Assays | 1 | 2017 | 13 | 0.540 |
Why?
|
| Oxygen | 3 | 2024 | 217 | 0.540 |
Why?
|
| Molecular Chaperones | 2 | 2024 | 68 | 0.540 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 64 | 0.530 |
Why?
|
| Polymers | 1 | 2018 | 151 | 0.530 |
Why?
|
| Drug Carriers | 1 | 2018 | 169 | 0.520 |
Why?
|
| Environmental Pollutants | 3 | 2025 | 198 | 0.520 |
Why?
|
| Peptide Fragments | 3 | 2016 | 301 | 0.510 |
Why?
|
| Parkinson Disease | 3 | 2020 | 207 | 0.510 |
Why?
|
| Trypanosoma cruzi | 1 | 2017 | 154 | 0.480 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 184 | 0.480 |
Why?
|
| Protozoan Proteins | 1 | 2017 | 196 | 0.470 |
Why?
|
| Lewy Bodies | 2 | 2016 | 29 | 0.470 |
Why?
|
| Models, Molecular | 6 | 2024 | 875 | 0.450 |
Why?
|
| Reactive Nitrogen Species | 1 | 2014 | 10 | 0.450 |
Why?
|
| Nitric Oxide | 4 | 2015 | 381 | 0.450 |
Why?
|
| Ethyl Methanesulfonate | 3 | 2005 | 6 | 0.430 |
Why?
|
| Electrons | 1 | 2013 | 74 | 0.400 |
Why?
|
| Gelatin | 2 | 2024 | 16 | 0.400 |
Why?
|
| Binding Sites | 3 | 2024 | 670 | 0.400 |
Why?
|
| Particle Size | 2 | 2024 | 267 | 0.390 |
Why?
|
| Amino Acids | 1 | 2013 | 150 | 0.390 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2012 | 4 | 0.390 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 972 | 0.390 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 979 | 0.380 |
Why?
|
| Protein Denaturation | 7 | 2008 | 41 | 0.380 |
Why?
|
| Nitrates | 1 | 2012 | 63 | 0.370 |
Why?
|
| Circular Dichroism | 2 | 2024 | 64 | 0.350 |
Why?
|
| Benzylidene Compounds | 1 | 2010 | 5 | 0.350 |
Why?
|
| Piperidones | 1 | 2010 | 9 | 0.340 |
Why?
|
| Protein Structure, Tertiary | 4 | 2017 | 427 | 0.340 |
Why?
|
| Proteostasis Deficiencies | 2 | 2021 | 2 | 0.340 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 63 | 0.330 |
Why?
|
| Protein Binding | 4 | 2024 | 1076 | 0.330 |
Why?
|
| Stress, Physiological | 1 | 2010 | 170 | 0.310 |
Why?
|
| Drug Delivery Systems | 3 | 2023 | 273 | 0.300 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1066 | 0.300 |
Why?
|
| Green Fluorescent Proteins | 3 | 2016 | 207 | 0.290 |
Why?
|
| Metals, Heavy | 2 | 2025 | 69 | 0.290 |
Why?
|
| Peptide Mapping | 1 | 2008 | 20 | 0.280 |
Why?
|
| Neurons | 3 | 2022 | 1246 | 0.280 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 82 | 0.280 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 140 | 0.270 |
Why?
|
| Algorithms | 2 | 2016 | 508 | 0.250 |
Why?
|
| Ligands | 3 | 2017 | 387 | 0.250 |
Why?
|
| Drug Design | 3 | 2018 | 183 | 0.240 |
Why?
|
| Thiadiazoles | 1 | 2024 | 6 | 0.230 |
Why?
|
| Structure-Activity Relationship | 4 | 2024 | 491 | 0.230 |
Why?
|
| Acetic Acid | 1 | 2024 | 19 | 0.220 |
Why?
|
| Unfolded Protein Response | 1 | 2024 | 21 | 0.220 |
Why?
|
| Aluminum | 1 | 2024 | 39 | 0.220 |
Why?
|
| Locomotion | 1 | 2025 | 104 | 0.220 |
Why?
|
| Plastics | 1 | 2024 | 13 | 0.220 |
Why?
|
| Polystyrenes | 1 | 2024 | 20 | 0.220 |
Why?
|
| Myoglobin | 1 | 2024 | 18 | 0.220 |
Why?
|
| Liver | 2 | 2024 | 503 | 0.220 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2008 | 458 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 415 | 0.210 |
Why?
|
| Birds | 1 | 2025 | 93 | 0.210 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2024 | 89 | 0.210 |
Why?
|
| Pyridines | 1 | 2024 | 134 | 0.210 |
Why?
|
| Vitamin A | 1 | 2024 | 85 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 2 | 2023 | 189 | 0.210 |
Why?
|
| Green Chemistry Technology | 1 | 2023 | 6 | 0.210 |
Why?
|
| Surface Properties | 1 | 2024 | 157 | 0.210 |
Why?
|
| Ionic Liquids | 1 | 2023 | 20 | 0.210 |
Why?
|
| Central Nervous System Diseases | 1 | 2023 | 32 | 0.210 |
Why?
|
| Materials Testing | 1 | 2023 | 99 | 0.200 |
Why?
|
| Thiazolidinediones | 1 | 2024 | 49 | 0.200 |
Why?
|
| Sulfhydryl Compounds | 1 | 2003 | 49 | 0.200 |
Why?
|
| Antimalarials | 1 | 2024 | 63 | 0.200 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 62 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2023 | 136 | 0.200 |
Why?
|
| Pesticides | 1 | 2023 | 59 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2024 | 169 | 0.200 |
Why?
|
| Thermodynamics | 4 | 2016 | 226 | 0.200 |
Why?
|
| Homeostasis | 1 | 2024 | 193 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2023 | 150 | 0.190 |
Why?
|
| Rodentia | 1 | 2022 | 47 | 0.190 |
Why?
|
| Citric Acid | 1 | 2022 | 14 | 0.190 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2024 | 183 | 0.190 |
Why?
|
| beta-Glucans | 1 | 2022 | 11 | 0.190 |
Why?
|
| Kidney | 1 | 2024 | 363 | 0.190 |
Why?
|
| Nitrosation | 2 | 2012 | 5 | 0.180 |
Why?
|
| Selenious Acid | 1 | 2021 | 4 | 0.180 |
Why?
|
| Bacillus | 1 | 2021 | 12 | 0.180 |
Why?
|
| Coal | 1 | 2021 | 10 | 0.180 |
Why?
|
| Onions | 1 | 2021 | 11 | 0.170 |
Why?
|
| Soil Pollutants | 1 | 2022 | 104 | 0.170 |
Why?
|
| Biological Products | 1 | 2022 | 91 | 0.170 |
Why?
|
| Tissue Engineering | 1 | 2021 | 72 | 0.170 |
Why?
|
| Gene Expression | 1 | 2023 | 692 | 0.160 |
Why?
|
| Sequence Alignment | 2 | 2018 | 273 | 0.160 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 51 | 0.160 |
Why?
|
| Prions | 1 | 2020 | 23 | 0.160 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2020 | 51 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2021 | 121 | 0.160 |
Why?
|
| Agriculture | 1 | 2020 | 65 | 0.160 |
Why?
|
| Chitosan | 1 | 2020 | 52 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2008 | 385 | 0.160 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1020 | 0.150 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 15 | 0.150 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 167 | 0.150 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2018 | 52 | 0.150 |
Why?
|
| tau Proteins | 1 | 2020 | 182 | 0.150 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 522 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1420 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2017 | 189 | 0.140 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 1188 | 0.140 |
Why?
|
| Solvents | 1 | 2018 | 109 | 0.140 |
Why?
|
| Sulfur | 2 | 2016 | 21 | 0.140 |
Why?
|
| Databases, Protein | 2 | 2016 | 54 | 0.140 |
Why?
|
| Nucleic Acids | 1 | 2017 | 26 | 0.130 |
Why?
|
| Sulfur Compounds | 1 | 2016 | 7 | 0.130 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 185 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 221 | 0.130 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 128 | 0.130 |
Why?
|
| Chagas Disease | 1 | 2017 | 101 | 0.130 |
Why?
|
| Cytosol | 1 | 2016 | 98 | 0.130 |
Why?
|
| Picrates | 1 | 2016 | 7 | 0.120 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2017 | 110 | 0.120 |
Why?
|
| Limonins | 1 | 2016 | 4 | 0.120 |
Why?
|
| Cell Line | 1 | 2020 | 1416 | 0.120 |
Why?
|
| Biphenyl Compounds | 1 | 2016 | 52 | 0.120 |
Why?
|
| Isomerism | 2 | 2008 | 65 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 223 | 0.120 |
Why?
|
| Phenylenediamines | 1 | 2015 | 8 | 0.120 |
Why?
|
| Cyclohexylamines | 1 | 2015 | 12 | 0.120 |
Why?
|
| Proteomics | 1 | 2018 | 363 | 0.120 |
Why?
|
| Guanidine | 3 | 2004 | 10 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 201 | 0.120 |
Why?
|
| Transfection | 1 | 2016 | 526 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2016 | 411 | 0.120 |
Why?
|
| Cysteine | 3 | 2005 | 101 | 0.120 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 11 | 0.110 |
Why?
|
| PC12 Cells | 1 | 2014 | 93 | 0.110 |
Why?
|
| Brain | 1 | 2022 | 1452 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 78 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 928 | 0.110 |
Why?
|
| Azadirachta | 1 | 2013 | 3 | 0.110 |
Why?
|
| Mice | 3 | 2024 | 6490 | 0.100 |
Why?
|
| Organoplatinum Compounds | 2 | 2003 | 18 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2018 | 271 | 0.100 |
Why?
|
| Dopamine | 1 | 2015 | 272 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2024 | 232 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 69 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 206 | 0.100 |
Why?
|
| Plant Leaves | 1 | 2013 | 134 | 0.100 |
Why?
|
| Enzyme Stability | 3 | 2007 | 35 | 0.100 |
Why?
|
| Mitochondrial Diseases | 1 | 2012 | 19 | 0.100 |
Why?
|
| Necrosis | 1 | 2012 | 54 | 0.100 |
Why?
|
| Ecosystem | 2 | 2025 | 171 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2024 | 560 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 79 | 0.090 |
Why?
|
| Caspases | 1 | 2012 | 148 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 309 | 0.090 |
Why?
|
| Rana pipiens | 3 | 2007 | 62 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2013 | 303 | 0.080 |
Why?
|
| Flavonoids | 1 | 2010 | 94 | 0.080 |
Why?
|
| Rats | 2 | 2014 | 3701 | 0.080 |
Why?
|
| Phenols | 1 | 2010 | 102 | 0.080 |
Why?
|
| Biochemical Phenomena | 1 | 2009 | 2 | 0.080 |
Why?
|
| Food Chain | 1 | 2009 | 20 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 680 | 0.070 |
Why?
|
| Complex Mixtures | 1 | 2008 | 9 | 0.070 |
Why?
|
| Plants | 1 | 2009 | 114 | 0.070 |
Why?
|
| Aged | 1 | 2020 | 7982 | 0.070 |
Why?
|
| Organic Chemicals | 1 | 2007 | 35 | 0.070 |
Why?
|
| Peptides, Cyclic | 1 | 2007 | 29 | 0.070 |
Why?
|
| Oligosaccharides | 1 | 2005 | 28 | 0.060 |
Why?
|
| Time Factors | 2 | 2007 | 1848 | 0.060 |
Why?
|
| Male | 2 | 2024 | 22779 | 0.060 |
Why?
|
| Environmental Pollution | 1 | 2025 | 26 | 0.060 |
Why?
|
| Methylamines | 1 | 2004 | 14 | 0.060 |
Why?
|
| India | 1 | 2025 | 105 | 0.060 |
Why?
|
| Malondialdehyde | 1 | 2024 | 42 | 0.060 |
Why?
|
| Gram-Negative Bacteria | 1 | 2024 | 27 | 0.060 |
Why?
|
| Protective Agents | 1 | 2024 | 26 | 0.060 |
Why?
|
| Catalase | 1 | 2024 | 111 | 0.050 |
Why?
|
| Lactalbumin | 1 | 2004 | 6 | 0.050 |
Why?
|
| Phosphatidylserines | 1 | 2004 | 21 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2004 | 19 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2004 | 35 | 0.050 |
Why?
|
| Transition Temperature | 1 | 2003 | 9 | 0.050 |
Why?
|
| Dithioerythritol | 1 | 2003 | 1 | 0.050 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 33 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2023 | 48 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2025 | 226 | 0.050 |
Why?
|
| Triazoles | 1 | 2024 | 100 | 0.050 |
Why?
|
| Candida albicans | 1 | 2024 | 173 | 0.050 |
Why?
|
| Indoles | 1 | 2024 | 178 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2018 | 139 | 0.050 |
Why?
|
| Biodegradation, Environmental | 1 | 2022 | 82 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 37 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2025 | 845 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 1112 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2022 | 256 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 279 | 0.040 |
Why?
|
| Calcium | 1 | 2004 | 487 | 0.040 |
Why?
|
| Agrochemicals | 1 | 2020 | 6 | 0.040 |
Why?
|
| Soil | 1 | 2022 | 170 | 0.040 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 36 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 711 | 0.040 |
Why?
|
| Vertebrates | 1 | 2018 | 33 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 121 | 0.040 |
Why?
|
| Anemia | 1 | 2018 | 52 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 60 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 35 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2018 | 217 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2018 | 88 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 136 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2018 | 67 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2018 | 94 | 0.030 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2016 | 10 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 228 | 0.030 |
Why?
|
| Static Electricity | 1 | 2016 | 85 | 0.030 |
Why?
|
| Trypsin | 2 | 2008 | 40 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 48 | 0.030 |
Why?
|
| Plasmodium falciparum | 1 | 2016 | 146 | 0.030 |
Why?
|
| Autophagy | 1 | 2016 | 136 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 233 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 548 | 0.030 |
Why?
|
| West Indies | 1 | 2014 | 13 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 38 | 0.030 |
Why?
|
| Methylnitrosourea | 1 | 2013 | 2 | 0.030 |
Why?
|
| Bacteria | 1 | 2016 | 285 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2013 | 78 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 580 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 1737 | 0.020 |
Why?
|
| Anura | 1 | 2008 | 34 | 0.020 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2007 | 6 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 729 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2005 | 169 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 293 | 0.010 |
Why?
|
| Structural Homology, Protein | 1 | 2004 | 14 | 0.010 |
Why?
|
| Entropy | 1 | 2004 | 13 | 0.010 |
Why?
|
| Spin Labels | 1 | 2004 | 12 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2004 | 41 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 2003 | 14 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2003 | 25 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 103 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 135 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2004 | 56 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2004 | 205 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 457 | 0.010 |
Why?
|
| Phosphines | 1 | 2002 | 7 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 602 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 1058 | 0.010 |
Why?
|
| Female | 1 | 2013 | 24018 | 0.010 |
Why?
|